Chemotherapy In Breast Cancer

Chemotherapy In Breast Cancer

Chemotherapy in breast cancer

Iksempra – new drug for chemotherapy

Mammology – Breast surgery – – 2008

When a tumor does not respond to any medication, talk about what has developed resistance to this drug. This means that tumor cells somehow learn to cope with chemotherapy. This happens when chemotherapy destroys not all cancer cells. These surviving cells gradually develop. Sometimes you may need a longer course of chemotherapy, or a higher dose. But sometimes require different treatment.

The FDA has approved new drug application iksempra (ixempra – iksabepilon) for the treatment of common forms of breast cancer when other chemotherapy drugs have no effect. In particular, this new drug is used in combination with Xeloda (capecitabine).

Iksempra belongs to a new group of drugs – epothilone. The principle of operation is similar to that of taxanes, which include Taxol and Taxotere. And iksemra and taxanes affect the process of division and multiplication of cancer cells. Researchers believe that iksempra can be effective in advanced breast cancer because it is more difficult to develop resistance.

Studies have shown that the drug was effective iksempra in advanced breast cancer when standard chemotherapy did not give the desired effect. Compared with a single application iksempry, the combination of Xeloda gave a more lasting effect. But so far it is not clear whether the use of the drug iksempra improve survival in patients with advanced breast cancer.

Breast Center Dr. FALBREDE – GERMANY

Mammology in MOSCOW – Medical Center Health Institute

Examination and treatment in GERMANY – Institute "DIAGNOSTIX"

The use of anthracycline chemotherapy and tamoxifen
Chemotherapy in elderly patients with breast cancer and lymph node lesions
The drug is powerless – strengthening the immune system
Taxotere and abraksan in chemotherapy for breast cancer

Incoming search terms:

  • chemotherapy